Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis

Author:

Kishi Taro1,Ikuta Toshikazu2,Oya Kazuto1,Matsunaga Shinji13,Matsuda Yuki4,Iwata Nakao1

Affiliation:

1. Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan

2. Department of Communication Sciences and Disorders, School of Applied Sciences, University of Mississippi, MS USA

3. Department of Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Aichi, Japan

4. Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Reference44 articles.

1. Allen T , McEvoyJ, KeefeR(2003)Galantamine as an adjunctive therapy in the treatment of schizophrenia. Paper presented at: 11th Congress of the International Psychogeriatric Association (IPA); August 17–22, 2003; Chicago, IL.

2. Negative symptoms in schizophrenia. Definition and reliability;Andreasen;Arch Gen Psychiatry,1982

3. Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology;Arnold;Schizophr Bull,1996

4. A randomized clinical trial of oxytocin or galantamine for the treatment of negative symptoms and cognitive impairments in people with schizophrenia;Buchanan;J Clin Psychopharmacol,2017

5. Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy;Choi;Br J Psychiatry,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3